Nootkatol

Details

Top
Internal ID 509e7442-9d2b-41fd-973e-094e052f79c1
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Eremophilane, 8,9-secoeremophilane and furoeremophilane sesquiterpenoids
IUPAC Name (2S,4R,4aS,6R)-4,4a-dimethyl-6-prop-1-en-2-yl-3,4,5,6,7,8-hexahydro-2H-naphthalen-2-ol
SMILES (Canonical) CC1CC(C=C2C1(CC(CC2)C(=C)C)C)O
SMILES (Isomeric) C[C@@H]1C[C@@H](C=C2[C@]1(C[C@@H](CC2)C(=C)C)C)O
InChI InChI=1S/C15H24O/c1-10(2)12-5-6-13-8-14(16)7-11(3)15(13,4)9-12/h8,11-12,14,16H,1,5-7,9H2,2-4H3/t11-,12-,14+,15+/m1/s1
InChI Key GFNWRKNVTHDNPV-UXOAXIEHSA-N
Popularity 12 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24O
Molecular Weight 220.35 g/mol
Exact Mass 220.182715385 g/mol
Topological Polar Surface Area (TPSA) 20.20 Ų
XlogP 3.90
Atomic LogP (AlogP) 3.70
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
BETA-NOOTKATOL
50763-67-2
2S-Hydroxyvalencene
CHEBI:81378
(2S,4R,4aS,6R)-4,4a-dimethyl-6-prop-1-en-2-yl-3,4,5,6,7,8-hexahydro-2H-naphthalen-2-ol
(2S,4R,4aS,6R)-4,4a-dimethyl-6-(prop-1-en-2-yl)-2,3,4,4a,5,6,7,8-octahydronaphthalen-2-ol
trans-nootkatol
(+)-nootkatol
(+)-trans-nootkatol
2alpha-hydroxyvalencene
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Nootkatol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9956 99.56%
Caco-2 + 0.8541 85.41%
Blood Brain Barrier - 0.5500 55.00%
Human oral bioavailability - 0.5857 58.57%
Subcellular localzation Lysosomes 0.6186 61.86%
OATP2B1 inhibitior - 0.8553 85.53%
OATP1B1 inhibitior + 0.9280 92.80%
OATP1B3 inhibitior + 0.9348 93.48%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.5250 52.50%
BSEP inhibitior - 0.8364 83.64%
P-glycoprotein inhibitior - 0.9178 91.78%
P-glycoprotein substrate - 0.7575 75.75%
CYP3A4 substrate + 0.5655 56.55%
CYP2C9 substrate - 0.6499 64.99%
CYP2D6 substrate - 0.6843 68.43%
CYP3A4 inhibition - 0.7830 78.30%
CYP2C9 inhibition - 0.7663 76.63%
CYP2C19 inhibition - 0.6462 64.62%
CYP2D6 inhibition - 0.9386 93.86%
CYP1A2 inhibition - 0.7453 74.53%
CYP2C8 inhibition - 0.7310 73.10%
CYP inhibitory promiscuity - 0.8350 83.50%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.8900 89.00%
Carcinogenicity (trinary) Non-required 0.5600 56.00%
Eye corrosion - 0.9852 98.52%
Eye irritation - 0.7755 77.55%
Skin irritation + 0.6657 66.57%
Skin corrosion - 0.9400 94.00%
Ames mutagenesis - 0.8500 85.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5000 50.00%
Micronuclear - 0.9800 98.00%
Hepatotoxicity - 0.6300 63.00%
skin sensitisation + 0.5577 55.77%
Respiratory toxicity - 0.6444 64.44%
Reproductive toxicity + 0.8444 84.44%
Mitochondrial toxicity + 0.7000 70.00%
Nephrotoxicity - 0.6884 68.84%
Acute Oral Toxicity (c) III 0.8768 87.68%
Estrogen receptor binding - 0.7999 79.99%
Androgen receptor binding - 0.7396 73.96%
Thyroid receptor binding - 0.6854 68.54%
Glucocorticoid receptor binding - 0.6165 61.65%
Aromatase binding + 0.6572 65.72%
PPAR gamma - 0.7692 76.92%
Honey bee toxicity - 0.8092 80.92%
Biodegradation + 0.5250 52.50%
Crustacea aquatic toxicity + 0.6100 61.00%
Fish aquatic toxicity + 0.9898 98.98%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.62% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 94.76% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.70% 91.11%
CHEMBL1994 P08235 Mineralocorticoid receptor 91.97% 100.00%
CHEMBL241 Q14432 Phosphodiesterase 3A 90.88% 92.94%
CHEMBL3137262 O60341 LSD1/CoREST complex 87.96% 97.09%
CHEMBL4040 P28482 MAP kinase ERK2 85.52% 83.82%
CHEMBL5608 Q16288 NT-3 growth factor receptor 85.20% 95.89%
CHEMBL1951 P21397 Monoamine oxidase A 84.33% 91.49%
CHEMBL226 P30542 Adenosine A1 receptor 83.88% 95.93%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 83.68% 82.69%
CHEMBL1871 P10275 Androgen Receptor 81.24% 96.43%
CHEMBL1806 P11388 DNA topoisomerase II alpha 81.03% 89.00%

Cross-Links

Top
PubChem 182645
NPASS NPC53877
LOTUS LTS0021355
wikiData Q27155315